ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent

June 24, 2011

DCT Board Okays New Surgery RFA, Will Hear Request For Support Of 30 Surgical Centers

April 11, 1980

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

August 16, 1985

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008